Alesco Financial Inc. expected to Report Q3 2009 Results on November 9, 2009. This event was calculated by Capital IQ (Created on November 2, 2009).

Alesco Financial Inc., Annual General Meeting, Dec 15, 2009, at 10:00 US Eastern Time. Location: The Cira Centre, 2929 Arch Street, Philadelphia, Pennsylvania, United States. Agenda: To approve the election of directors and matters relating to the proposed merger of Cohen & Company with a subsidiary of AFN.

Alesco Financial Inc. said that as previously disclosed, on October 10, 2008 Alesco Financial Inc. received written notice from the New York Stock Exchange, Inc. that the Company was not in compliance with the NYSE’s continued listing standard under Section 802.01C of the NYSE Listed Company Manual. The standard requires the average closing price of any listed security not to fall below $1.00 per share for any consecutive 30 trading-day period. The Company notified the NYSE of the Company’s intent to cure the deficiency by effectuating a 1-for-10 reverse stock split of its outstanding shares of common stock. The Company had six months from the date of the NYSE’s notice to bring its share price and average share price back above $1.00. The NYSE subsequently announced several temporary reprieves from the NYSE’s minimum share price requirement for all NYSE-listed companies. After giving effect to those reprieves, the Company’s six-month cure period was due to expire on September 13, 2009. On September 4, 2009, the NYSE notified the Company that the NYSE would further extend the cure period until the Company’s next annual meeting of stockholders, which is expected to take place later in 2009. In addition to its regular annual meeting business, the Company expects that its proposed merger with Cohen Brothers, LLC will be submitted to stockholders for their consideration at the meeting. The Company expects to effectuate the reverse stock split in conjunction with the merger. If the merger is terminated and then Company does not promptly effectuate the reverse stock split, then the Company could be subject to suspension and delisting procedures by the NYSE. Even if the merger is consummated, there can be no assurance that the Company will be able to maintain compliance with the NYSE’s listing standards or the listing standards of any other exchange on which the Company’s common stock may be listed.